← Back to Clinical Trials
Recruiting NCT02369770

NCT02369770 Sensory-Motor Rehabilitation Post Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02369770
Status Recruiting
Phase
Sponsor University of Maryland, Baltimore
Condition Acute Stroke
Study Type INTERVENTIONAL
Enrollment 140 participants
Start Date 2019-04-26
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
stretching and active movement training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 140 participants in total. It began in 2019-04-26 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Early after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devices for early intensive sensorimotor therapy.This research study will conduct a randomized clinical trial of an intensive motor-sensory rehabilitation on patients with acute stroke using a wearable rehabilitation robot. The primary aims are to facilitate sensorimotor recovery, reduce ankle impairments, and improve balance and gait functions. This clinical trial will be conducted on the Study and Control groups of acute stroke survivors.

Eligibility Criteria

Inclusion Criteria: 1. First time unilateral acute stroke, hemorrhagic or ischemic, 24 hours after admission in hospital to 1 year post stroke. 2. Hemiplegia or hemiparesis 3. Age 18-80 4. Ankle impairments Exclusion Criteria: 1. No impairment or very mild ankle impairment of ankle. 2. Unstable medical conditions that interferes with ability to training and exercise. 3. Severe cardiovascular disorders that interfere with ability to perform moderate movement exercises. 4. Cognitive impairment or aphasia with inability to follow instructions 5. Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee of treated limb 6. Severe pain in legs

Contact & Investigator

Central Contact

Raziyeh Baghi, Ph.D.

✉ rbaghi@som.umaryland.edu

📞 (410) 706-5717

Principal Investigator

Li-Qun Zhang, Ph.D.

PRINCIPAL INVESTIGATOR

University of Maryland, Baltimore

Frequently Asked Questions

Who can join the NCT02369770 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02369770 currently recruiting?

Yes, NCT02369770 is actively recruiting participants. Contact the research team at rbaghi@som.umaryland.edu for enrollment information.

Where is the NCT02369770 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT02369770 clinical trial?

NCT02369770 is sponsored by University of Maryland, Baltimore. The principal investigator is Li-Qun Zhang, Ph.D. at University of Maryland, Baltimore. The trial plans to enroll 140 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology